| Primary |
| Product Used For Unknown Indication |
43.2% |
| Hiv Infection |
42.3% |
| Malaria Prophylaxis |
5.7% |
| Drug Use For Unknown Indication |
2.4% |
| Prophylaxis Against Hiv Infection |
2.0% |
| Acquired Immunodeficiency Syndrome |
1.4% |
| Prophylaxis |
0.7% |
| Malaria |
0.6% |
| Convulsion |
0.5% |
| Anaemia Of Pregnancy |
0.4% |
| Tuberculosis |
0.4% |
| Antibiotic Prophylaxis |
0.1% |
| Diabetes Mellitus |
0.1% |
| Pregnancy |
0.1% |
| Sinusitis |
0.1% |
|
| Neutropenia |
27.2% |
| Vomiting |
17.5% |
| Sepsis |
7.8% |
| Abortion Spontaneous |
5.8% |
| Death |
3.9% |
| Abortion Incomplete |
2.9% |
| Fracture |
2.9% |
| Hemiparesis |
2.9% |
| Intestinal Obstruction |
2.9% |
| Pneumonia Bacterial |
2.9% |
| Pulmonary Tuberculosis |
2.9% |
| Renal Failure |
2.9% |
| Thrombocytopenia |
2.9% |
| Tuberculosis |
2.9% |
| Abortion Induced |
1.9% |
| Anaemia |
1.9% |
| Bronchopneumonia |
1.9% |
| Diarrhoea |
1.9% |
| Drug Exposure During Pregnancy |
1.9% |
| Gastritis |
1.9% |
|
| Secondary |
| Hiv Infection |
57.4% |
| Malaria Prophylaxis |
18.6% |
| Product Used For Unknown Indication |
12.0% |
| Antiretroviral Therapy |
2.7% |
| Drug Exposure During Pregnancy |
2.2% |
| Malaria |
2.2% |
| Acquired Immunodeficiency Syndrome |
1.6% |
| Prophylaxis |
1.6% |
| Pregnancy |
1.1% |
| Drug Use For Unknown Indication |
0.5% |
|
| Neutropenia |
46.2% |
| Vomiting |
10.3% |
| Thrombocytopenia |
7.7% |
| Abortion Spontaneous |
5.1% |
| Anaemia |
5.1% |
| Bronchopneumonia |
5.1% |
| Paraesthesia |
5.1% |
| Fracture |
2.6% |
| Hypersensitivity |
2.6% |
| Intra-uterine Death |
2.6% |
| Photophobia |
2.6% |
| Pneumonia Bacterial |
2.6% |
| Pneumonia Klebsiella |
2.6% |
|
| Interacting |
| Product Used For Unknown Indication |
57.1% |
| Convulsion |
28.6% |
| Acquired Immunodeficiency Syndrome |
14.3% |
|
| Drug Level Below Therapeutic |
50.0% |
| Multi-organ Failure |
50.0% |
|
